Adrenocortical cancer and IGF2: is the game over or our experimental models limited?

Adrenocortical carcinoma. Endocr Rev (2013) 1.46

Adrenocortical zonation, renewal, and remodeling. Front Endocrinol (Lausanne) (2015) 0.80

Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature. World J Surg Oncol (2015) 0.78

Mouse models of adrenocortical tumors. Mol Cell Endocrinol (2015) 0.78

Genomic and immunohistochemical analysis in human adrenal cortical neoplasia reveal beta-catenin mutations as potential prognostic biomarker. Discoveries (Craiova) (2015) 0.75

Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St. Jude and Children's Oncology Group Study. Clin Cancer Res (2016) 0.75

P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model. Oncogene (2017) 0.75

Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum Mol Genet (2010) 1.38

Wnt/β-catenin signalling in adrenal physiology and tumour development. Mol Cell Endocrinol (2011) 1.15

Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice. PLoS Genet (2010) 1.09

Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J Clin Endocrinol Metab (2014) 1.07

WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. Hum Mol Genet (2013) 1.05

Adrenocorticotropin-dependent changes in SF-1/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis. Endocrinology (2006) 0.98

Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes. Mol Endocrinol (2004) 0.97

A transgenic mouse line with specific Cre recombinase expression in the adrenal cortex. Mol Cell Endocrinol (2008) 0.96

Transcriptional control of adrenal steroidogenesis: novel connection between Janus kinase (JAK) 2 protein and protein kinase A (PKA) through stabilization of cAMP response element-binding protein (CREB) transcription factor. J Biol Chem (2011) 0.95

Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions. PLoS One (2009) 0.95

Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. J Clin Endocrinol Metab (2004) 0.94

Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models. PLoS One (2012) 0.93

In vivo evidence for the crucial role of SF1 in steroid-producing cells of the testis, ovary and adrenal gland. Development (2012) 0.93

The cAMP pathway and the control of adrenocortical development and growth. Mol Cell Endocrinol (2011) 0.90

The transcription co-factor CITED2 functions during sex determination and early gonad development. Hum Mol Genet (2009) 0.88

Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice. PLoS Genet (2013) 0.82

Steroidogenic factor-1 controls the aldose reductase akr1b7 gene promoter in transgenic mice through an atypical binding site. Endocrinology (2003) 0.80

Aldose reductases influence prostaglandin F2α levels and adipocyte differentiation in male mouse and human species. Endocrinology (2015) 0.77

Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia. Endocr Relat Cancer (2015) 0.75